Related Experiment Video
Updated: Sep 1, 2025

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Pediatric precision oncology-Time for clinical prime time
Stefan M Pfister1, Olaf Witt2, David T W Jones3
1Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
Molecular tumor profiling is feasible and clinically useful in pediatric cancer patients. This study supports a collaborative approach to pediatric precision oncology in the US.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Prospective molecular tumor-profiling studies are increasingly used in pediatric cancer.
- These studies demonstrate feasibility and clinical utility across diverse healthcare systems.
- Previous research has laid the foundation for precision oncology in young patients.
Purpose of the Study:
- To substantiate the value of molecular tumor profiling in pediatric oncology.
- To establish a framework for a systematic, collaborative pediatric precision oncology initiative in the US.
Main Methods:
- The study builds upon previous prospective molecular tumor-profiling research.
- It analyzes data from pediatric cancer patients within various healthcare systems.
Main Results:
- Molecular tumor profiling is confirmed as feasible in pediatric cancer care.
- The clinical utility of this approach is further substantiated.
- The study provides a foundation for future collaborative efforts.
Conclusions:
- Molecular tumor profiling is a valuable tool in pediatric oncology.
- A systematic, collaborative approach is essential for advancing pediatric precision oncology in the US.
Related Concept Videos
Preclinical Development: Overview
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials: Overview

